UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms

Cell, 2013-05, Vol.153 (5), p.1050-1063

2013

Link zum Volltext

Verfügbarkeit prüfen

Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA

The Journal of molecular diagnostics : JMD, 2020-07, Vol.22 (7), p.943-956

2020

Link zum Volltext

Verfügbarkeit prüfen

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

International journal of cancer, 2022-12, Vol.151 (12), p.2161-2171

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer

BMC cancer, 2021-01, Vol.21 (1), p.49-49, Article 49

2021

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Scientific reports, 2017-07, Vol.7 (1), p.4510-11, Article 4510

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures

Cancers, 2020-06, Vol.12 (6), p.1440

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors

Nature communications, 2021-06, Vol.12 (1), p.1-12, Article 3807

2021

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

BMC cancer, 2017-11, Vol.17 (1), p.781-781, Article 781

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.17562848211002018-17562848211002018

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma

Scientific reports, 2021-04, Vol.11 (1), p.7499-7499, Article 7499

2021

Link zum Volltext

Verfügbarkeit prüfen

Study Protocol for a Randomised Controlled Trial on Pulmonary Metastasectomy vs. Standard of Care in Colorectal Cancer Patients With ≥ 3 Lung Metastases (PUCC-Trial)

Frontiers in oncology, 2022-07, Vol.12, p.913896-913896

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma

Frontiers in genetics, 2018-04, Vol.9, p.108-108

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting ALK in Neuroendocrine Tumors of the Lung

Frontiers in oncology, 2022-06, Vol.12, p.911294-911294

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer

JCO precision oncology, 2021-11, Vol.5, p.1082

2021

Link zum Volltext

Verfügbarkeit prüfen

Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?

Cancers, 2023-09, Vol.15 (17), p.4398

2023

Link zum Volltext

Verfügbarkeit prüfen

Repeated SBRT for in- and out-of-field recurrences in the liver

Strahlentherapie und Onkologie, 2019-03, Vol.195 (3), p.246-253

2019

Link zum Volltext

Verfügbarkeit prüfen

Translational Repression of MCL-1 Couples Stress-induced eIF2α Phosphorylation to Mitochondrial Apoptosis Initiation

The Journal of biological chemistry, 2007-08, Vol.282 (31), p.22551-22562

2007

Link zum Volltext

Verfügbarkeit prüfen

Multi-target ddPCR Assays zur Detektion von KRAS- und NRAS-Mutationen

Biospektrum, 2020-11, Vol.26 (6), p.629-634

2020

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition

Cancers, 2021-04, Vol.13 (8), p.1852

2021

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin

Cancers, 2022-09, Vol.14 (17), p.4275

2022

Link zum Volltext

Verfügbarkeit prüfen

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer

Oncotarget, 2017-03, Vol.8 (10), p.17164-17190

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities

Oncology research and treatment, 2021-02, Vol.44 (1-2), p.1-3

2021

Link zum Volltext

Verfügbarkeit prüfen

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management

Diagnostics (Basel), 2020-08, Vol.10 (8), p.550

2020

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Scientific reports, 2017-10, Vol.7 (1), p.14631-1, Article 14631

2017

Link zum Volltext

Verfügbarkeit prüfen

Precision Oncology for Hepato-Pancreato-Biliary (HPB) Cancers: State of the Art and Future Directions

Healthbook TIMES. Oncology Hematology, 2020-10, Vol.5 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(84)
Japanisch
(15)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms

Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures

Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma

Study Protocol for a Randomised Controlled Trial on Pulmonary Metastasectomy vs. Standard of Care in Colorectal Cancer Patients With ≥ 3 Lung Metastases (PUCC-Trial)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma

Targeting ALK in Neuroendocrine Tumors of the Lung

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer

Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?

Repeated SBRT for in- and out-of-field recurrences in the liver

Translational Repression of MCL-1 Couples Stress-induced eIF2α Phosphorylation to Mitochondrial Apoptosis Initiation

Multi-target ddPCR Assays zur Detektion von KRAS- und NRAS-Mutationen

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition

Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer

Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Precision Oncology for Hepato-Pancreato-Biliary (HPB) Cancers: State of the Art and Future Directions

Suchergebnisse filtern